Technologies Development and Expertise
We have been innovating the immuno-oncology sector with our following listed key discoveries by using the state-of-the-art technologies
Compounds in Pipeline
Program
Monoclonal antibody
Monoclonal antibody
Small molecule
Small molecule
Discovery/Research
Preclinical
Clinical PoC Trials
Clinical Trial
Phase-I
Clinical Trial
Phase-II
Clinical Trial
Phase-III
NDA Filed
(FDA filing)
AOM-201901
AOM-202001
AOM-Rare-202101
AOM-Covid19-202002
Technologies under development
Phase-1
Conceptualization
Phase-2
Proof of Concept
Phase-3
Testing & Validation
Phase-4
Launch & Marketing
Phase-5
Scaling & Establishing
Onco-Cure
Immuno-Oncology data analysis pipeline
MULTIOMICS-ImmunoAI
Multi-omics based AI pipeline
Technologies/tools we utilise
AI/ML Development
Application Development
Blockchain Development
Would you like to start a project with us?
Reach out on the given number or write us an email for further queries regarding project requirements